Changing the standard sequence of treatment for operable pancreatic cancer could improve survival for some patients, say researchers. Some patients with operable disease and elevated levels of the CA ...
Second interim analysis of the Global Investigation of Therapeutic Decisions in Unresectable HCC (uHCC) and of Its Treatment with Sorafenib (GIDEON): Differences in AE reporting across physician ...
“To our knowledge, there are no studies evaluating the prognostic importance of CEA and Ca 19-9 in patients with DA [duodenal adenocarcinoma].” Duodenal adenocarcinoma (DA) is a rare malignancy ...
Three hundred eighty-five patients patients had assessable CA 19-9 levels. The majority had a CA 19-9 level lower than 180 or ≤ 90 (n = 220 and 200, respectively), while 34% were Lewis Antigen ...
Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The ...
“[...] these inexpensive, widely available tests with rapid turnaround times and relatively short half-lives (CEA, CA-125, and CA19-9) are perfectly situated to ...
Please provide your email address to receive an email when new articles are posted on . The blood test reliably detected patients with stage I and II pancreatic ductal adenocarcinoma with 97% accuracy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results